Featured Research

from universities, journals, and other organizations

Experts Predict High Mortality Rates From Pulmonary Fibrosis Will Continue To Rise

Date:
August 6, 2007
Source:
American Thoracic Society
Summary:
Mortality rates from pulmonary fibrosis have increased significantly in recent years, and are predicted to continue to rise, according to researchers. Between 1992 and 2003, the age-adjusted mortality rate from PF -- an often fatal disease which involves scarring of the lung -- rose by nearly 28.4 percent in men, and 41.3 percent in women. Over the same time period, an increasing percentage of patients with PF died of the disease itself rather than of coexisting conditions.

Mortality rates from pulmonary fibrosis (PF) have increased significantly in recent years, and are predicted to continue to rise, according to researchers from the University of Colorado.

Related Articles


Between 1992 and 2003, the age-adjusted mortality rate from PF--an often fatal disease which involves scarring of the lung--rose by nearly 28.4 percent in men, and 41.3 percent in women. Over the same time period, an increasing percentage of patients with PF died of the disease itself rather than of coexisting conditions.

"Rates rise with increasing age, are highest among older people, and are consistently higher in men than in women," wrote the researchers. "However, mortality rates in women with PF are climbing more rapidly than in men."

The study, led by Amy Olsen, M.D., M.S.P.H., of the University of Colorado Health Sciences Center, appears in the August 1, 2007, issue to the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Dr. Olson and five colleagues analyzed the cause of death listed on death certificates for more than 28 million decedents using data compiled by the National Center for Health Statistics. Of that larger group, more than 175,000 deaths were linked to PF. In developing a model to predict future mortality rates, the researchers applied a multivariable analysis to current data, finding a predicted significant increase in men over the age of 65 and for women in all age categories.

"Our study is the first large-scale study to examine age-, sex-, race-, and ethnicity-stratified mortality rates in decedents with PF," said Dr. Olson.

In addition to finding a large disparity in mortality rates among women and men, which researchers suggest may be attributable to changes in historically gendered smoking patterns, they also found significant differences among racial and ethnic lines. Age-adjusted mortality rates among whites were higher than among blacks or Hispanics and increasing more quickly than in other racial and ethnic groups. Although previous studies have suggested that whites are more likely to be diagnosed with PF, differences in race or ethnicity "may also play a role in susceptibility," the researchers note, and merit further examination.

The investigators also found significant geographical variation in mortality rates, but were unable to determine whether these differences represent true differences in mortality rates, which would suggest an environmental factor in the pathogenesis of PF, or if differences reflect variation in diagnostic criteria used and testing available in different localities, or variation in coding and certifying cause-of-death on death certificates.

"Although we were unable to determine the underlying cause of the geographic variation using this dataset, these differences warrant further exploration," Dr. Olson said.

Similarly, the researchers were unable to determine whether the increased percentage of patients with PF dying from the disease itself represents an improvement in treatments for commonly co-existing conditions such as cardiovascular disease, reflects diagnostic changes, or the result of a new classification system implemented in 1997 that excludes patients with more hopeful prognoses.

"Although once considered an orphan disease, our results suggest that PF should no longer be considered a rarity," Dr. Olson concluded, noting that current death rates for the disease are higher than multiple myeloma and bladder cancer "These findings indicate an important and growing problem and provide an argument for more resources focused on the pathobiology of and therapy for this disease."


Story Source:

The above story is based on materials provided by American Thoracic Society. Note: Materials may be edited for content and length.


Cite This Page:

American Thoracic Society. "Experts Predict High Mortality Rates From Pulmonary Fibrosis Will Continue To Rise." ScienceDaily. ScienceDaily, 6 August 2007. <www.sciencedaily.com/releases/2007/08/070801091334.htm>.
American Thoracic Society. (2007, August 6). Experts Predict High Mortality Rates From Pulmonary Fibrosis Will Continue To Rise. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2007/08/070801091334.htm
American Thoracic Society. "Experts Predict High Mortality Rates From Pulmonary Fibrosis Will Continue To Rise." ScienceDaily. www.sciencedaily.com/releases/2007/08/070801091334.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins